| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Hutson Nancy J58 | Director | Buy | 10,000 | $0.86 | $8,600.00 | +12.0% | +51.9% | +57.8% | |
| Sep 25, 2023 | Thorp Clay62 | Director | Buy | 10,000 | $0.86 | $8,600.00 | +32.8% | +35.3% | +34.7% | |
| Jan 20, 2023 | Ciulla Thomas72 | Chief Medical Officer | Sell | 13,700 | $1.47 | $20,139.00 | -4.5% | -25.3% | -14.0% | |
| Jan 19, 2023 | Lasezkay George M71 | CEO | Sell | 20,030 | $1.46 | $29,243.80 | -4.0% | -21.8% | -12.2% | |
| Jan 19, 2023 | Deignan Charles A.69 | Chief Financial Officer | Sell | 14,030 | $1.50 | $21,045.00 | -3.7% | -21.8% | -12.2% | |
| Jan 10, 2023 | Ciulla Thomas72 | Chief Medical Officer | Sell | 2,170 | $1.62 | $3,515.40 | -0.7% | -25.3% | -14.5% | |
| Dec 21, 2022 | Thorp Clay62 | Director | Buy | 14,000 | $1.02 | $14,266.00 | +84.7% | +2.0% | +4.0% | |
| Nov 17, 2022 | Hutson Nancy J58 | Director | Buy | 30,000 | $1.33 | $39,900.00 | +56.6% | -0.7% | -29.4% | |
| Jan 19, 2022 | Deignan Charles A.69 | Chief Financial Officer | Sell | 8,833 | $2.09 | $18,460.97 | -2.5% | -7.1% | -30.3% | |
| Jan 19, 2022 | Ciulla Thomas72 | Chief Medical Officer | Sell | 9,050 | $2.13 | $19,276.50 | -3.0% | -7.1% | -30.3% |